Skip to content Skip to footer
Viewpoints_Atray Dixit

PharmaShots Interview: Coral Genomics’s Atray Dixit Shares Insights on the 2021 Innovation Challenge in Inflammatory Bowel Disease

In an interview with PharmaShots, Atray Dixit, Co-founder & CEO at Coral Genomics share his views on the winner of the $25K inflammatory bowel disease innovation challenge under the collaboration with Lyfebulb and ArenaShots:Lyfebulb and Arena collaborated to discover 2021 Imagining Life Without Limits Challenge to get the solutions for patients with IBDCoral Genomics was selected as…

Read more